Pure Biologics (WAR:PUR) OCF Margin %: 0.00% (As of Mar. 2026)


WAR:PUR Pure Biologics SA WAR:PUR
19 GF Score
Price zł2.35
! 2 Warning Signs
View Full Analysis

What is Pure Biologics OCF Margin %?

Pure Biologics WAR:PUR -3.69% 19 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates WAR:PUR with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 958 Biotechnology companies, Pure Biologics ranks worse than 104384.03% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Pure Biologics's Cash Flow from Operations for the three months ended in Mar. 2026 was zł-3.17 Mil. Pure Biologics's Revenue for the three months ended in Mar. 2026 was zł0.00 Mil. Therefore, Pure Biologics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Pure Biologics's current OCF Yield % is -30.00%.

The historical rank and industry rank for Pure Biologics's OCF Margin % or its related term are showing as below:


During the past 10 years, the highest OCF Margin % of Pure Biologics was 389.30%. The lowest was -9462.60%. And the median was -236.54%.

WAR:PUR's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Pure Biologics OCF Margin % Related Terms

Pure Biologics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Pure Biologics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pure Biologics OCF Margin % Chart

Pure Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9,462.60 -2,626.44 0.00 0.00 0.00

Pure Biologics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:PUR
19GF Score
Pure Biologics SA WAR:PUR
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pure Biologics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Pure Biologics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.248/0
= %

Pure Biologics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-3.169/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Pure Biologics (WAR:PUR) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pure Biologics and its competitors. According to the industry distribution chart, Pure Biologics ranks #999999 out of 958 companies in the Biotechnology industry.
Is Pure Biologics' OCF Margin % too high?
Pure Biologics' current OCF Margin % is 0.00%. Based on the distribution chart, Pure Biologics ranks #999999 out of 958 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Pure Biologics has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pure Biologics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pure Biologics ranks #999999 out of 958 companies for OCF Margin %. This places Pure Biologics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pure Biologics and its competitors. Pure Biologics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pure Biologics stock overvalued right now?
Pure Biologics (WAR:PUR) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Pure Biologics' overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Pure Biologics (WAR:PUR), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pure Biologics Business Description

Address ul. Dunska 11, Wroclaw, POL, 54-427
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.
19GF Score

Get the complete analysis for WAR:PUR

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.35
Price